Beranda › Poliradikuloneuropati Demielinasi Inflamasi Kronis › Texas › Houston
Uji klinis Poliradikuloneuropati Demielinasi Inflamasi Kronis di Houston, TX
6 studi untuk Poliradikuloneuropati Demielinasi Inflamasi Kronis mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 2
- Site Number - 1622, Houston
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Menerima pesertaFase 3
- NeuroCarePlus, Houston
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Menerima pesertaFase 3
- NeuroCarePlus, Houston
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 3
- Uthealth - The University Of Texas Health Sciences Center At Houston- Site Number : 8400050, Houston
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Menerima pesertaFase 3
- Cinical Study Site, Houston
- Texas Locations, Houston
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Menerima pesertaFase 2
- Houston Methodist Research Institute, Houston
Uji klinis Poliradikuloneuropati Demielinasi Inflamasi Kronis di kota lain
- New York City, NY7 studi
- Miami, FL6 studi
- Kansas City, KS5 studi
- Indio, CA5 studi
- Philadelphia, PA5 studi
- New Haven, CT5 studi
- St. Louis, MO5 studi
- Tampa, FL4 studi
- Cleveland, OH4 studi
- Milwaukee, WI4 studi
- Washington, DC4 studi
- Birmingham, AL4 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.